by Gabriel Oke | Nov 8, 2024 | Uncategorized
Antimicrobial resistance (AMR) presents a looming threat to healthcare systems worldwide, with the potential to render routine treatments ineffective and even minor infections life-threatening. Yui Kohno, a manager at the Health and Global Policy Institute (HGPI) in...
by Gabriel Oke | Nov 8, 2024 | Uncategorized
Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, particularly with the rise of multidrug-resistant TB (MDR-TB). For years, the standard approach to treating TB has followed a “one-size-fits-all” regimen, but that may soon change,...
by Gabriel Oke | Nov 8, 2024 | Uncategorized
Matthias Eberl, a professor of translational immunology at Cardiff University (Wales, UK) and Michael Mosha, a dedicated pharmacist and researcher in Dodoma (Tanzania), are joining forces to tackle the global issue of antimicrobial resistance (AMR) through science,...
by Gabriel Oke | Nov 8, 2024 | Uncategorized
Dr. Jonas R. Henriksen, who holds a PhD in physical chemistry from the Technical University of Denmark, is making significant progress in the fields of drug delivery and antimicrobial resistance (AMR). His career began in biophysics, providing a strong scientific...
by Gabriel Oke | Nov 8, 2024 | Uncategorized
In the fight against antimicrobial resistance (AMR), groundbreaking research is crucial for developing new strategies to combat resistant bacteria. Two scientists, Fredrik Westerlund and Hana Sipova-Jungova, are bringing their unique expertise and innovative...
